Pharmaceuticals: Major · attribution context sourced from stored price moves, stored event labels, and peer-relative residuals inside the XLV constituent company universe.
Review priority 100 · Source rank 0 · Volume 6.8x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +0.15% · Sector -0.48% · Industry -0.24% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -23.71%Review priority 100 · Source rank 0 · Volume 12.2x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro -1.90% · Sector +0.37% · Industry +0.05% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -22.33%Review priority 93 · Source rank 0 · Volume 5.9x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro -0.30% · Sector +0.41% · Industry -0.25% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -14.91%Review priority 90 · Source rank 0 · Volume 4.9x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro -1.27% · Sector -0.31% · Industry +0.28% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -13.58%Review priority 87 · Source rank 0 · Volume 10.8x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro -0.45% · Sector +0.80% · Industry +0.04% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +12.18%Review priority 83 · Source rank 0 · Volume 3.3x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +0.93% · Sector -0.72% · Industry +0.03% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +11.61%Review priority 81 · Source rank 0 · Volume 4.0x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +0.19% · Sector -0.58% · Industry -0.04% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -9.45%Review priority 75 · Source rank 54 · Volume 1.1x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +8.25% · Sector -6.17% · Industry -0.57% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +11.98%| Date | Label | Move | Residual after context | Scope | Confidence |
|---|---|---|---|---|---|
| Mar 13, 2020 | Broad market moved +8.25% with this stock | +13.50% | +11.98% | Macro | 58% |
| May 13, 2019 | Broad market moved -2.91% with this stock | -9.43% | -8.00% | Macro | 58% |
| May 18, 2020 | Broad market moved +4.27% with this stock | +8.58% | +7.76% | Macro | 58% |
| Aug 14, 2019 | Broad market moved -3.16% with this stock | -8.52% | -7.36% | Macro | 58% |
| Mar 18, 2020 | Broad market moved -5.94% with this stock | -8.93% | -7.02% | Macro | 58% |
| Feb 27, 2025 | Viatris Inc. 10-K: 10-K | -15.21% | -0.58% | Direct | 70% |
| Feb 27, 2025 | Viatris Inc. 8-K: 8-K | -15.21% | -0.58% | Direct | 70% |
| Feb 27, 2025 | NASDAQ:VTRS annual report filing | -15.21% | -0.58% | Direct | 94% |
| Nov 7, 2024 | Viatris Inc. 10-Q: 10-Q | +13.52% | +0.51% | Direct | 70% |
| Nov 7, 2024 | Viatris Inc. 8-K: 8-K | +13.52% | +0.51% | Direct | 70% |